Literature DB >> 27037866

Prolonged Ischemic Time, Delayed Graft Function, and Graft and Patient Outcomes in Live Donor Kidney Transplant Recipients.

A R Krishnan1, G Wong2,3,4,5, J R Chapman3, P T Coates6, G R Russ2,6, H Pleass3, C Russell6, B He1, W H Lim1,2.   

Abstract

The association between prolonged cold ischemic time (CIT) and graft and patient outcomes in live donor kidney transplant recipients remains unclear. The aims of this study were to examine the association of CIT with delayed graft function and graft loss in live donor kidney transplant recipients and those who participated in the Australian Paired Kidney Exchange program using data from the Australia and New Zealand Dialysis and Transplant (ANZDATA) registry. Of 3717 live donor transplant recipients between 1997 and 2012 who were followed for a median of 6.6 years (25 977 person-years), 224 (25%) experienced CIT >4-8 h. Donor age was an effect modifier between CIT and graft outcomes. In recipients who received kidneys from older donors aged >50 years, every hour of increase in CIT was associated with adjusted odds of 1.28 (95% confidence interval [CI] 1.07-1.53, p = 0.007) for delayed graft function, whereas CIT >4-8 h was associated with adjusted hazards of 1.93 (95% CI 1.21-3.09, p = 0.006) and 1.91 (95% CI 1.05-3.49, p = 0.035) for overall and death-censored graft loss, respectively, compared with CIT of 1-2 h. Attempts to reduce CIT in live donor kidney transplants involving older donor kidneys may lead to improvement of graft outcomes. © Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/practice; delayed graft function (DGF); graft survival; health services and outcomes research; infection and infectious agents; kidney (allograft) function/dysfunction; kidney transplantation/nephrology; kidney transplantation: living donor

Mesh:

Year:  2016        PMID: 27037866     DOI: 10.1111/ajt.13817

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  11 in total

1.  Risk factors for delayed graft function and their impact on graft outcomes in live donor kidney transplantation.

Authors:  Shivashankar Damodaran; Brenna Bullock; Obi Ekwenna; Mehdi Nayebpour; Naoru Koizumi; Puneet Sindhwani; Jorge Ortiz
Journal:  Int Urol Nephrol       Date:  2021-01-04       Impact factor: 2.370

2.  The National Kidney Registry: Time to Buy In?

Authors:  Bushra Syed; Joshua J Augustine
Journal:  Clin J Am Soc Nephrol       Date:  2020-01-28       Impact factor: 8.237

3.  Pretransplant transcriptomic signature in peripheral blood predicts early acute rejection.

Authors:  Weijia Zhang; Zhengzi Yi; Chengguo Wei; Karen L Keung; Zeguo Sun; Caixia Xi; Christopher Woytovich; Samira Farouk; Lorenzo Gallon; Madhav C Menon; Ciara Magee; Nader Najafian; Milagros D Samaniego; Arjang Djamali; Stephen I Alexander; Ivy A Rosales; Rex Neal Smith; Philip J O'Connell; Robert Colvin; Paolo Cravedi; Barbara Murphy
Journal:  JCI Insight       Date:  2019-06-06

Review 4.  Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation.

Authors:  Maarten Naesens; Alexandre Loupy; Luuk Hilbrands; Rainer Oberbauer; Maria Irene Bellini; Denis Glotz; Josep Grinyó; Uwe Heemann; Ina Jochmans; Liset Pengel; Marlies Reinders; Stefan Schneeberger; Klemens Budde
Journal:  Transpl Int       Date:  2022-05-20       Impact factor: 3.842

5.  The first 9 years of kidney paired donation through the National Kidney Registry: Characteristics of donors and recipients compared with National Live Donor Transplant Registries.

Authors:  Stuart M Flechner; Alvin G Thomas; Matthew Ronin; Jeffrey L Veale; David B Leeser; Sandip Kapur; John D Peipert; Dorry L Segev; Macey L Henderson; Ashton A Shaffer; Matthew Cooper; Garet Hil; Amy D Waterman
Journal:  Am J Transplant       Date:  2018-04-30       Impact factor: 8.086

6.  Clinical relevance of cell-free mitochondrial DNA during the early postoperative period in kidney transplant recipients.

Authors:  Kipyo Kim; Haena Moon; Yu Ho Lee; Jung-Woo Seo; Yang Gyun Kim; Ju-Young Moon; Jin Sug Kim; Kyung-Hwan Jeong; Tae Won Lee; Chun-Gyoo Ihm; Sang-Ho Lee
Journal:  Sci Rep       Date:  2019-12-09       Impact factor: 4.379

Review 7.  Shifting Paradigms for Suppressing Fibrosis in Kidney Transplants: Supplementing Perfusion Solutions With Anti-fibrotic Drugs.

Authors:  L Leonie van Leeuwen; Henri G D Leuvenink; Peter Olinga; Mitchel J R Ruigrok
Journal:  Front Med (Lausanne)       Date:  2022-01-10

8.  Shipping living donor kidneys and transplant recipient outcomes.

Authors:  Eric Treat; Eric K H Chow; John D Peipert; Amy Waterman; Lorna Kwan; Allan B Massie; Alvin G Thomas; Mary Grace Bowring; David Leeser; Stuart Flechner; Marc L Melcher; Sandip Kapur; Dorry L Segev; Jeffrey Veale
Journal:  Am J Transplant       Date:  2017-12-18       Impact factor: 9.369

Review 9.  Ischemia-Reperfusion Injury Reduces Long Term Renal Graft Survival: Mechanism and Beyond.

Authors:  Hailin Zhao; Azeem Alam; Aurelie Pac Soo; Andrew J T George; Daqing Ma
Journal:  EBioMedicine       Date:  2018-02-02       Impact factor: 8.143

Review 10.  The Impact of Cold Ischaemia Time on Outcomes of Living Donor Kidney Transplantation: A Systematic Review and Meta-Analysis.

Authors:  Stijn C van de Laar; Jeffrey A Lafranca; Robert C Minnee; Vassilios Papalois; Frank J M F Dor
Journal:  J Clin Med       Date:  2022-03-15       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.